Use of biochemical markers to predict the outcome of pregnancies conceived by in vitro fertilization;In vitro fertilizáció útján fogant terhességek kimenetelének elorejelzése biokémiai markerekkel

Orvosi Hetilap

Volumn 147, Issue 30, 2006, Pages 1409-1420

  Hauzman, Erik ^a,b   Murber, Ákos ^a   Fancsovits, Péter ^a   Papp, Zoltán ^a   Urbancsek, János ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NONE

Author keywords

CA 125; Human choriogonadotropin (hCG); In vitro fertilization (IVF); Inhibin A; Pregnancy outcome

Indexed keywords

BIOCHEMICAL MARKER; CA 125 ANTIGEN; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; INHIBIN A; BIOLOGICAL MARKER; INHIBIN; TRANSFORMING GROWTH FACTOR BETA;

ADVERSE OUTCOME; ARTICLE; DIAGNOSTIC ACCURACY; EMBRYO TRANSFER; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONE BLOOD LEVEL; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LOGISTIC REGRESSION ANALYSIS; MULTIPLE PREGNANCY; OOCYTE DONATION; PREDICTION; PREGNANCY OUTCOME; PROGNOSIS; PROTEIN DETERMINATION; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SPONTANEOUS ABORTION; ADULT; BLOOD; FEMALE; FIRST TRIMESTER PREGNANCY; MATHEMATICAL COMPUTING; PREDICTION AND FORECASTING; PREGNANCY; ROC CURVE;

ABORTION, SPONTANEOUS; ADULT; BIOLOGICAL MARKERS; CA-125 ANTIGEN; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; FERTILIZATION IN VITRO; HUMANS; INHIBINS; MATHEMATICAL COMPUTING; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PREGNANCY, MULTIPLE; PROGNOSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TRANSFORMING GROWTH FACTOR BETA;

EID: 33749322000     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Baalbergen, A., Janssen, J. W., van der Weiden, R. M.: CA-125 levels are related to the likelihood of pregnancy after in vitro fertilization and embryo transfer. Am. J. Reprod. Immunol., 2000, 43, 21-24.
2. Barbieri, R. L., Niloff, J. M., Bast, R. C., Jr. és mtsai: Elevated serum concentrations of CA-125 in patients with advanced endometriosis. Fertil. Steril., 1986, 45, 630-634.
3. Birdsall, M., Ledger, W., Groome, N. és mtsai: Inhibin A and activin A in the first trimester of human pregnancy. J. Clin. Endocrinol. Metab., 1997, 82, 1557-1560.
4. Bjercke, S., Tanbo, T., Dale, P. O. és mtsai: Human chorionic gonadotrophin concentrations in early pregnancy after in-vitro fertilization. Hum. Reprod., 1999, 14, 1642-1646.
5. Bon, G. G., Kenemans, P., Dekker, J. J. és mtsai: Fluctuations in CA 125 and CA 15-3 serum concentrations during spontaneous ovulatory cycles. Hum. Reprod., 1999, 14, 566-570.
6. Burger, H. G., Igarashi, M.: Inhibin: definition and nomenclature, including related substances. J. Clin. Endocrinol. Metab., 1988, 66, 885-886.
7. Chard, T.: Frequency of implantation and early pregnancy loss in natural cycles. Bailliere's Clin. Obstet. Gynaecol., 1991, 5, 179-189.
8. Edwards, R. G., Fishel, S. B., Cohen, J. és mtsai: Factors influencing the success of in vitro fertilization for alleviating human infertility. J. In Vitro Fert. Embryo Transf., 1984, 1, 3-23.
9. Fridström, M., Garoff, L., Sjöblom, P. és mtsa: Human chorionic gonadotropin patterns in early pregnancy after assisted reproduction. Acta Obstet. Gynecol. Scand., 1995, 74, 534-538.
10. Glatstein, I. Z., Hornstein, M. D., Kahana, M. J. és mtsai: The predictive value of discriminatory human chorionic gonadotropin levels in the diagnosis of implantation outcome in vitro fertilization cycles. Fertil. Steril., 1995, 63, 350-356.
11. Guth, B., Hudelson, J., Higbie, J. és mtsai: Predictive value of hCG level 14 days after embryo transfer. J. Assist. Reprod. Genet., 1995, 12, 13-14.
12. Halila, H., Stenman, U. H., Seppälä, M.: Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy. Cancer, 1986, 57, 1327-1329.
13. Hanley, J. A., McNeil, B. J.: A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology, 1983, 148, 839-843.
14. Hauzman, E., Fedorcsák, P., Klinga, K. és mtsai: Use of serum inhibin A and human chorionic gonadotropin measurements to predict the outcome of in vitro fertilization pregnancies. Fertil. Steril., 2004, 81, 66-72.
15. Hauzman, E., Lagarde, A. R., Osztovits, J. és mtsai: Prognostic value of serum CA-125 measurements on stimulation day 1 and on the day of oocyte pickup in the prediction of IVF treatment outcome. J. Assist. Reprod. Genet., 2005, 22, 265-268.
16. Heiner, J. S., Kerin, J. F., Schmidt, L. L. és mtsa: Can a single, early quantitative human chorionic gonadotropin measurement in an in vitro fertilization-gamete intrafallopian transfer program predict pregnancy outcome? Fertil. Steril., 1992, 58, 373-377.
17. Illingworth, P. J., Groome, N. P., Duncan, W. C. és mtsai: Measurement of circulating inhibin forms during the establishment of pregnancy. J. Clin. Endocrinol. Metab., 1996, 81, 1471-1475.
18. Illingworth, P. J., Reddi, K., Smith, K. és mtsa: Pharmacological 'rescue' of the corpus luteum results in increased inhibin production. Clin. Endocrinol. (Oxf.), 1990, 33, 323-332.
19. Jäger, W., Diedrich, K., Wildt, L.: Elevated levels of CA-125 in serum of patients suffering from ovarian hyperstimulation syndrome. Fertil. Steril., 1987, 48, 675-678.
20. Kadar, N., DeVore, G., Romero, R.: Discriminatory hCG zone: its use in the sonographic evaluation for ectopic pregnancy. Obstet. Gynecol., 1981, 58, 156-161.
21. Kingsley, D. M.: The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev., 1994, 8, 133-146.
22. Legro, R. S., Paulson, R. J., Lobo, R. A. és mtsa: Association of early beta-human chorionic gonadotrophin values with pregnancy wastage and multiple implantation in a donor oocyte programme. Hum. Reprod., 1995, 10, 3293-3296.
23. Lenton, E. A., de Kretser, D. M., Woodward, A. J. és mtsai: Inhibin concentrations throughout the menstrual cycles of normal, infertile, and older women compared with those during spontaneous conception cycles. J. Clin. Endocrinol. Metab., 1991, 73, 1180-1190.
24. Lockwood, G. M., Ledger, W. L., Barlow, D. H. és mtsai: Measurement of inhibin and activin in early human pregnancy: demonstration of fetoplacental origin and role in prediction of early-pregnancy outcome. Biol. Reprod., 1997, 57, 1490-1494.
25. Lockwood, G. M., Ledger, W. L., Barlow, D. H. és mtsai: Identification of the source of inhibins at the time of conception provides a diagnostic role for them in very early pregnancy. Am. J. Reprod. Immunol., 1998, 40, 303-308.
26. Miller, K. A., Deaton, J. L., Pittaway, D. E.: Evaluation of serum CA 125 concentrations as predictors of pregnancy with human in vitro fertilization. Fertil. Steril., 1996, 65, 1184-1189.
27. Morris, N. M., Udry, J. R.: Daily immunologic pregnancy testing of initially nonpregnant women. Am. J. Obstet. Gynecol., 1967, 98, 1148-1150.
28. Muttukrishna, S., Child, T. J., Groome, N. P. és mtsa: Source of circulating levels of inhibin A, pro alpha C-containing inhibins and activin A in early pregnancy. Hum. Reprod., 1997, 12, 1089-1093.
29. Niloff, J. M., Knapp, R. C., Schaetzl, E. és mtsai: CA125 antigen levels in obstetric and gynecologic patients. Obstet. Gynecol., 1984, 64, 703-707.
30. Nyboe, A. A., Gianaroli, L., Nygren, K. G.: Assisted reproductive technology in Europe, 2000. Results generated from European registers by ESHRE. Hum. Reprod., 2004, 19, 490-503.
31. Ozaksit, G., Turhan, N. O., Oral, H. és mtsai: Relationship between serum CA 125 levels, endometrial thickness and corpus luteum function in different stages of ovarian activity. J. Endocrinol. Invest., 1993, 16, 175-179.
32. Petraglia, F., Garuti, G. C., Calzá, L. és mtsai: Inhibin subunits in human placenta: localization and messenger ribonucleic acid levels during pregnancy. Am. J. Obstet. Gynecol., 1991, 165, 750-758.
33. Petraglia, F., Sawchenko, P., Lim, A. T. és mtsai: Localization, secretion, and action of inhibin in human placenta. Science, 1987, 237, 187-189.
34. Pittaway, D. E., Reish, R. L., Wentz, A. C.: Doubling times of human chorionic gonadotropin increase in early viable intrauterine pregnancies. Am. J. Obstet. Gynecol., 1985, 152, 299-302.
35. Poikkeus, P., Hiilesmaa, V., Tiitinen, A.: Serum HCG 12 days after embryo transfer in predicting pregnancy outcome. Hum. Reprod., 2002, 17, 1901-1905.
36. Predanic, M.: Differentiating tubal abortion from viable ectopic pregnancy with serum CA-125 and beta-human chorionic gonadotropin determinations. Fertil. Steril., 2000, 73, 522-525.
37. Rombauts, L., Verhoeven, G., Meuleman, C. és mtsai: Dimeric inhibin A and alpha-subunit immunoreactive material in maternal serum during spontaneous and in vitro fertilization pregnancies. J. Clin. Endocrinol. Metab., 1996, 81, 985-989.
38. Shapiro, B. S., Escobar, M., Makuch, R. és mtsai: A model-based prediction for transvaginal ultrasonographic identification of early intrauterine pregnancy. Am. J. Obstet. Gynecol., 1992, 166, 1495-1500.
39. Slama, R., Eustache, F., Ducot, B. és mtsai: Time to pregnancy and semen parameters: a cross-sectional study among fertile couples from four European cities. Hum. Reprod., 2002, 17, 503-515.
40. Stray-Pedersen, B., Stray-Pedersen, S.: Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am. J. Obstet. Gynecol., 1984, 148, 140-146.
41. Sugantha, S. E., Webster, S., Sundar, E. és mtsa: Predictive value of plasma human chorionic gonadotrophin following assisted conception treatment. Hum. Reprod., 2000, 15, 469-473.
42. Tavmergen, E., Sendag, F., Goker, E. N. és mtsa: Value of serum CA-125 concentrations as predictors of pregnancy in assisted reproduction cycles. Hum. Reprod., 2001, 16, 1129-1134.
43. Tree-tampinich, C., O'Connor, A. E., MacLachlan, V. és mtsai: Maternal serum inhibin A concentrations in early pregnancy after IVF and embryo transfer reflect the corpus luteum contribution and pregnancy outcome. Hum. Reprod., 2000, 15, 2028-2032.
44. Urbancsek, J., Hauzman, E., Fedorcsák, P. és mtsai: Serum human chorionic gonadotropin measurements may predict pregnancy outcome and multiple gestation after in vitro fertilization. Fertil. Steril., 2002, 78, 540-542.
45. Urbancsek, J., Hauzman, E. E., Lagarde, A. R. és mtsai: Serum CA-125 levels in the second week after embryo transfer predict clinical pregnancy. Fertil. Steril., 2005, 83, 1414-1421.
46. Vujisić, S., Kupešić, S., Mihaljević, D. és mtsai: Evaluation of serum CA 125 concentration before and during hormonal induced cycles as predictor of IVF/ET outcome. Am. J. Reprod. Immunol., 2002, 48, 355-360.
47. Wilke, G., Hinney, B., Rath, W. és mtsai: [CA-125 serum level in early pregnancy follow hMG/hCG stimulated and unstimulated cycles]. Geburtshilfe Frauenheilkd., 1990, 50, 941-946.
48. Yamoto, M., Minami, S., Nakano, R.: Immunohistochemical localization of inhibin subunits in human corpora lutea during menstrual cycle and pregnancy. J. Clin. Endocrinol. Metab., 1991, 73, 470-477.
49. Zeimet, A. G., Müller-Holzner, E., Marth, C. és mtsai: Tumor marker CA-125 in tissues of the female reproductive tract and in serum during the normal menstrual cycle. Fertil. Steril., 1993, 59, 1028-1035.
50. Zweig, M. H., Campbell, G.: Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem., 1993, 39, 561-577.